demonstrated that exposure to thiamethoxam, a major neonicotinoid compound, promotes MASLD through S-adenosylmethionine depletion and methyl donor imbalance mediated by NNMT, thereby disrupting PPAR signaling (Yang et al

Treatment Protocols DSIP therapy at Strong Health follows a structured clinical approach: Sleep assessment: Thorough evaluation of sleep patterns, sleep hygiene practices, medical history, and current medications Baseline metrics: Sleep questionnaires, and when indicated, referral for sleep studies to rule out sleep apnea or other primary sleep disorders Protocol design: Physician determines DSIP dosing, timing, and whether combination with other peptides is appropriate Administration: DSIP is typically administered via subcutaneous injection in the evening, 12 hours before desired sleep onset Monitoring: Regular follow-ups to assess sleep quality improvements, adjust dosing, and track any side effects Sleep hygiene integration: Peptide therapy is combined with evidence-based sleep hygiene recommendations for optimal results Safety and Side Effects DSIP has a generally favorable safety profile based on available clinical data

In contrast, there is no research suggesting carnitine would be helpful for older adults, given that it is primarily used as a fat-burning agent rather than one that would help combat sarcopenia
Key considerations: Typical concentration: 50 mg per capsule Administration: Swallow whole with water